Stock search

Ticker or company name

Centene Corporation

CNC · NYSE · Health Care

$74,77Up +3,50 (+4,91%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$35,3 bn
Div. yield
—
Year to date
+70,8%
52 weeks: $31,63$78,08

Ratio score

72/100
Ratio would consider buying

based on 9 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

5 ✓ · 3 — · 1 ✕ · 1 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM24,217,325,1
Forward P/E13,5—16,2
PEGn/a—2,2
P/S0,20,22,2
EV/EBITDA13,510,517,3
P/FCF4,0—19,5
P/B1,61,43,4

Industry median — across 33 profitable companies in “Health Care” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 27 analysts

Buy
13
Hold
13
Sell
1

Beat the EPS forecast in 4 of the last 4 quarters

QuarterEstimateActualSurprise
Q3 20260,100,16Up +65,1%
Q2 20261,102,51Up +129,0%
Q1 20262,153,37Up +56,4%
Q4 2025−1,24−1,19Up +3,7%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue50,6 bn53,6 bn49,9 bn49,7 bn49,7 bn48,7 bn46,6 bn40,8 bn42,0 bn39,8 bn40,4 bn39,5 bn
EPS−0,142,193,11−2,24−13,50−0,512,630,621,362,162,160,10
Margin−0,1%2,0%3,1%−2,2%−13,3%−0,5%2,8%0,7%1,7%2,9%2,9%0,1%
FCF−3,86 bn3,42 bn4,17 bn224 m1,15 bn1,58 bn1,38 bn−741 m−1,13 bn1,99 bn−607 m−6,00 m

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: no purchases, sales $14,6 m.

NameAmountSharesPrice
koster christopher26 Aug 2026 · sale$3,78 m56 500$66,90
koster christopher18 Aug 2026 · sale$3,11 m47 603$65,36
burdick kenneth a10 Jun 2026 · sale$5,16 m80 000$64,55
burdick kenneth a4 Dec 2025 · sale$1,28 m32 796$39,00
burdick kenneth a3 Dec 2025 · sale$1,30 m33 211$39,04

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Health Care
Exchange
NYSE
Country
US
IPO date
13 Dec 2001

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
RMDResMed$238,1983would consider21,3+9,0%27,8%
GEHCGE HealthCare$82,96no score17,4——
DXCMDexcom$81,6189would consider31,4+13,0%19,4%
LHLabcorp$372,4656would watch30,0+6,0%6,9%
DGXQuest Diagnostics$262,2161would watch25,5+9,1%9,5%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.